3000 Participants Needed

Text-Messaging Platform for Musculoskeletal Disorders

KW
PT
Overseen ByPaul Tornetta III, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Boston Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Memora Platform for PROMIS, Memora Health's Text-Messaging Platform, Memora Platform, Right-Size Clinic Visits for musculoskeletal disorders?

Research suggests that text message interventions can be effective in promoting healthy behavior and managing chronic diseases, including musculoskeletal pain. Although the effects on pain intensity and function are small and inconsistent, text messages have shown potential benefits in treatment adherence and quality of life when used as part of a multicomponent intervention.12345

Is the text-messaging platform for musculoskeletal disorders safe for humans?

The research on text message interventions for musculoskeletal pain suggests they are generally safe, with some positive effects on treatment adherence and quality of life, but the studies were of limited quality and more research is needed to confirm these findings.16789

How is the Right-Size Clinic Visits treatment for musculoskeletal disorders unique?

The Right-Size Clinic Visits treatment is unique because it uses a text-messaging platform to manage musculoskeletal disorders, which is a low-cost and accessible method that can improve treatment adherence and potentially enhance pain management and quality of life. This approach differs from traditional treatments by incorporating digital communication to support patient care.14101112

What is the purpose of this trial?

Developing novel methods of patient communication is crucial in providing value-based care to orthopedic patients. Healthcare technology platforms have been developed to improve patient communication methods particularly for the administration of patient-reported outcome measures (PROMs). However, the majority of these interventions rely on web-based platforms that require patients to have computer access. Among American households earning less than $30,000 per year, only 59% have access to a desktop or laptop and just 47% have broadband internet at home compared to mobile phone penetration which is estimated at 95% of which 93% regularly use text messages. The use of phone messaging may be the most effective means to have patients complete PROMs.The Patient-Reported Outcomes Measurement Information System (PROMIS) is an NIH-funded, clinically validated method of tracking patient-reported outcomes to efficiently assess patient health status. PROMIS utilizes Item Response Theory (IRT) and computerized adaptive testing (CAT) to improve measurement precision and decrease survey time as compared to traditional PROMs.The purpose of this two-phase study is to utilize Memora Health's text-messaging platform to collect web-based PROMIS CAT surveys from patients (Phase 1) and use this information to right-size clinic visits (Phase 2).

Research Team

PT

Paul Tornetta III, MD

Principal Investigator

Boston Medical Center

Eligibility Criteria

This trial is for orthopedic patients with specific conditions like lumbar fusion, ACL reconstruction, or rotator cuff repair. Participants must have a personal cell phone with internet and speak English primarily. It's not for incarcerated individuals, those who can't read well, or without a cell phone.

Inclusion Criteria

I have a broken ankle.
I have been diagnosed with lumbar stenosis.
I have had surgery to repair my rotator cuff.
See 12 more

Exclusion Criteria

Limited and non-readers
Vulnerable populations - incarcerated patients
Patients with no cell phone to use for scoring

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Phase 1

Participants complete PROMIS CAT questionnaires via SMS or secure weblink to assess health status and develop recovery curves

1 year
Standard follow-up clinic visits

Phase 2

Clinic visits are adjusted based on recovery curves; participants receive phone calls or in-person visits based on PROMs

1 year

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Memora Platform for PROMIS
  • Right-Size Clinic Visits
Trial Overview The study tests the use of Memora Health's text-messaging platform to collect patient-reported outcomes via PROMIS CAT surveys and then tailor clinic visits accordingly. The goal is to improve communication and care efficiency in two phases.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Phase 2Experimental Treatment1 Intervention
Participants in Phase 2 will have their clinic visits potentially revised based on the phase 1 recovery curves which may increase or decrease the number of clinic visits they receive based on the PROMs reported.
Group II: Phase 1Active Control1 Intervention
Participants in phase 1 will be observed and data about their recovery time will be collected from which recovery curves will be calculated for Phase 2

Find a Clinic Near You

Who Is Running the Clinical Trial?

Boston Medical Center

Lead Sponsor

Trials
410
Recruited
890,000+

Findings from Research

This systematic review analyzed 11 studies on the use of text message interventions for managing musculoskeletal pain, finding that while the overall quality of the studies was limited, there were some positive effects on treatment adherence and other outcomes like pain intensity and quality of life.
Text messages, when combined with usual care or multicomponent interventions, showed potential benefits in managing musculoskeletal pain, suggesting they could be a low-cost addition to treatment strategies, but further research is needed to confirm these findings.
Effects of using text message interventions for the management of musculoskeletal pain: a systematic review.Fritsch, CG., Ferreira, PH., Prior, JL., et al.[2021]
A study involving 42 patients with chronic musculoskeletal conditions found that telehealth assessments showed substantial agreement (83.3%) with in-person assessments regarding recommended management pathways.
The agreement for clinical diagnostics and further investigations was also high (83.3% and 81% respectively), indicating that telehealth is a viable and effective option for assessing patients who cannot attend in person.
Agreement between telehealth and in-person assessment of patients with chronic musculoskeletal conditions presenting to an advanced-practice physiotherapy screening clinic.Cottrell, MA., O'Leary, SP., Swete-Kelly, P., et al.[2019]
Digital physiotherapy assessments show acceptable to excellent validity and reliability for various components, such as clinical tests and patient-reported outcomes, based on a systematic review of 10 studies involving 193 participants.
Patients reported satisfaction with digital assessments, although they rated them lower than face-to-face assessments, indicating that while digital options are viable, they may not fully replace in-person evaluations.
Digital physiotherapy assessment vs conventional face-to-face physiotherapy assessment of patients with musculoskeletal disorders: A systematic review.Bernhardsson, S., Larsson, A., Bergenheim, A., et al.[2023]

References

Effects of using text message interventions for the management of musculoskeletal pain: a systematic review. [2021]
Agreement between telehealth and in-person assessment of patients with chronic musculoskeletal conditions presenting to an advanced-practice physiotherapy screening clinic. [2019]
Digital physiotherapy assessment vs conventional face-to-face physiotherapy assessment of patients with musculoskeletal disorders: A systematic review. [2023]
Development and use of mobile messaging for individuals with musculoskeletal pain conditions: a scoping review protocol. [2021]
Use of eHealth technologies to enable the implementation of musculoskeletal Models of Care: Evidence and practice. [2022]
Estimating the population health burden of musculoskeletal conditions using primary care electronic health records. [2021]
Usability Testing of a Digital Assessment Routing Tool: Protocol for an Iterative Convergent Mixed Methods Study. [2021]
Minimal clinical data sets for spine-related musculoskeletal disorders in primary care and outpatient settings: a scoping review protocol. [2022]
Analgesic prescribing for musculoskeletal complaints in the ambulatory care setting after the introduction and withdrawal of cyclooxygenase-2 inhibitors. [2015]
10.United Statespubmed.ncbi.nlm.nih.gov
Daily text messages used as a method for assessing low back pain among workers. [2016]
Usability Testing of a Digital Assessment Routing Tool for Musculoskeletal Disorders: Iterative, Convergent Mixed Methods Study. [2022]
Efficacy of an innovative smartphone application for office workers with chronic non-specific low back pain: a pilot randomized controlled trial. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security